Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Randomized Study of Letrozole and Trilostane for Medical Abortion

This study has been terminated.
(No access to study drug Trilostan. Company closed down)
Karolinska Institutet
The University of Hong Kong
Information provided by (Responsible Party):
Kristina Gemzell Danielsson, Karolinska Institutet Identifier:
First received: June 4, 2012
Last updated: May 15, 2015
Last verified: May 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2013
  Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)